-
1
-
-
6744266646
-
Comparison of human immunodeficiency virus type 1 Pr55(Gag) and Pr160(Gag-Pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitors
-
DOI 10.1128/AAC.44.5.1397-1403.2000
-
Speck RR, Flexner C, Tian CJ, Yu XF (2000) Comparison of human immunode fi ciency virus type 1 Pr55(Gag) and Pr160(Gag-pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitors. Antimicrob Agents Chemother 44:1397-1403. (Pubitemid 30228333)
-
(2000)
Antimicrobial Agents and Chemotherapy
, vol.44
, Issue.5
, pp. 1397-1403
-
-
Renae Speck, R.1
Flexner, C.2
Tian, C.-J.3
Xiao-Fang, Y.4
-
2
-
-
27744572130
-
Processing sites in the human immunode fi ciency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates
-
Pettit SC, Lindquist JN, Kaplan AH, Swanstrom R (2005) Processing sites in the human immunode fi ciency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates. Retrovirology 2:66.
-
(2005)
Retrovirology
, vol.2
, pp. 66
-
-
Pettit, S.C.1
Lindquist, J.N.2
Kaplan, A.H.3
Swanstrom, R.4
-
4
-
-
0031925586
-
Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites
-
Wiegers K, Rutter G, Kottler H, Tessmer U, Hohenberg H, Krausslich HG (1998) Sequential steps in human immunode fi ciency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J Virol 72:2846-2854. (Pubitemid 28175521)
-
(1998)
Journal of Virology
, vol.72
, Issue.4
, pp. 2846-2854
-
-
Wiegers, K.1
Rutter, G.2
Kottler, H.3
Tessmer, U.4
Hohenberg, H.5
Krausslich, H.-G.6
-
5
-
-
0023921610
-
Endoproteolytic cleavage of gp160 is required for the activation of human immunode fi ciency virus
-
McCune JM, Rabin LB, Feinberg MB, Lieberman M, Kosek JC, Reyes GR, Weissman IL (1988) Endoproteolytic cleavage of gp160 is required for the activation of human immunode fi ciency virus. Cell 53:55-67.
-
(1988)
Cell
, vol.53
, pp. 55-67
-
-
McCune, J.M.1
Rabin, L.B.2
Feinberg, M.B.3
Lieberman, M.4
Kosek, J.C.5
Reyes, G.R.6
Weissman, I.L.7
-
6
-
-
0029868289
-
Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases
-
Vollenweider F, Benjannet S, Decroly E, Savaria D, Lazure C, Thomas G, Chretien M, Seidah NG (1996) Comparative cellular processing of the human immunode fi ciency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases. Biochem J 314(Pt 2):521-532. (Pubitemid 26074766)
-
(1996)
Biochemical Journal
, vol.314
, Issue.2
, pp. 521-532
-
-
Vollenweider, F.1
Benjannet, S.2
Decroly, E.3
Savaria, D.4
Lazure, C.5
Thomas, G.6
Chretien, M.7
Seidah, N.G.8
-
7
-
-
77956216235
-
An assay to monitor HIV-1 protease activity for the identi fi cation of novel inhibitors in T-cells
-
Hilton BJ, Wolkowicz R (2010) An assay to monitor HIV-1 protease activity for the identi fi cation of novel inhibitors in T-cells. PLoS One 5:e10940.
-
(2010)
PLoS One
, vol.5
-
-
Hilton, B.J.1
Wolkowicz, R.2
-
9
-
-
0023001219
-
Functional domains of the yeast regulatory protein GAL4
-
DOI 10.1073/pnas.83.17.6553
-
Johnston SA, Zavortink MJ, Debouck C, Hopper JE (1986) Functional domains of the yeast regulatory protein GAL4. Proc Natl Acad Sci U S A 83:6553-6557. (Pubitemid 17174773)
-
(1986)
Proceedings of the National Academy of Sciences of the United States of America
, vol.83
, Issue.17
, pp. 6553-6557
-
-
Johnston, S.A.1
Zavortink, M.J.2
Debouck, C.3
Hopper, J.E.4
-
10
-
-
0026594052
-
A genetic system for studying the activity of a proteolytic enzyme
-
Dasmahapatra B, DiDomenico B, Dwyer S, Ma J, Sadowski I, Schwartz J (1992) A genetic system for studying the activity of a proteolytic enzyme. Proc Natl Acad Sci U S A 89: 4159-4162.
-
(1992)
Proc Natl Acad Sci U S A
, vol.89
, pp. 4159-4162
-
-
Dasmahapatra, B.1
Didomenico, B.2
Dwyer, S.3
Ma, J.4
Sadowski, I.5
Schwartz, J.6
-
11
-
-
0027434225
-
Inactivation of a yeast transactivator by the fused HIV-1 proteinase: A simple assay for inhibitors of the viral enzyme activity
-
Murray MG, Hung W, Sadowski I, Das Mahapatra B (1993) Inactivation of a yeast transactivator by the fused HIV-1 proteinase: a simple assay for inhibitors of the viral enzyme activity. Gene 134:123-128.
-
(1993)
Gene
, vol.134
, pp. 123-128
-
-
Murray, M.G.1
Hung, W.2
Sadowski, I.3
Das Mahapatra, B.4
-
12
-
-
0034869511
-
Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity
-
DOI 10.1128/AAC.45.9.2616-2622.2001
-
Lindsten K, Uhlikova T, Konvalinka J, Masucci MG, Dantuma NP (2001) Cell-based fl uorescence assay for human immunode fi ciency virus type 1 protease activity. Antimicrob Agents Chemother 45:2616-2622. (Pubitemid 32801919)
-
(2001)
Antimicrobial Agents and Chemotherapy
, vol.45
, Issue.9
, pp. 2616-2622
-
-
Lindsten, K.1
Uhlikova, T.2
Konvalinka, J.3
Massuci, M.G.4
Dantuma, N.P.5
-
13
-
-
0036058440
-
Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression
-
DOI 10.1006/viro.2001.1261
-
Mouland AJ, Coady M, Yao XJ, Cohen EA (2002) Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunode fi ciency virus type 1 Vpr expression. Virology 292:321-330. (Pubitemid 34920551)
-
(2002)
Virology
, vol.292
, Issue.2
, pp. 321-330
-
-
Mouland, A.J.1
Coady, M.2
Yao, X.-J.3
Cohen, E.A.4
-
14
-
-
0029996147
-
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
-
Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267. (Pubitemid 26119138)
-
(1996)
Science
, vol.272
, Issue.5259
, pp. 263-267
-
-
Naldini, L.1
Blomer, U.2
Gallay, P.3
Ory, D.4
Mulligan, R.5
Gage, F.H.6
Verma, I.M.7
Trono, D.8
|